查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1242129

細胞解離的全球市場

Cell Dissociation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

細胞解離的全球市場在2030年前將達到8億5,910萬美元

在COVID-19後改變的商務環境中，2022年3億5,640萬美元的細胞解離的全球市場，2030年之前將達到8億5,910萬美元的規模，在2022年～2030年預計將以年複合成長率11.6％增長。本報告所分析之市場區隔之一的酵素分解產品，年複合成長率將記錄12.6％，到分析期間結束時將達到4億5,680萬美元。考慮疫情後的復甦，非酵素分解產品領域今後8年的年複合成長率將修正為11.1％。

美國市場估算為1億710萬美元，中國則將以年複合成長率11.1％的速度成長。

美國的細胞解離市場在2022年估算為1億710萬美元。作為世界第2大經濟大國的中國，在2022年～2030年年複合成長率預計將為11.1％，在2030年前將達到1億4,870萬美元的市場規模。其他熱門的地區市場有日本和加拿大，在2022年～2030年預計將各以10.3％和9.7％的速度成長。在歐洲市場中，德國以年複合成長率8.3％成長。

調查對像企業範例

  • American Type Culture Collection(ATCC)
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HiMedia Laboratories
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • PAN-Biotech GmbH
  • StemCell Technologies Inc.
  • Thermo Fisher Scientific, Inc.

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 全球其他地區

第4章 競爭

簡介目錄
Product Code: MCP10940

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Cell Dissociation Market to Reach $859.1 Million by 2030

In the changed post COVID-19 business landscape, the global market for Cell Dissociation estimated at US$356.4 Million in the year 2022, is projected to reach a revised size of US$859.1 Million by 2030, growing at aCAGR of 11.6% over the period 2022-2030. Enzymatic Dissociation Products, one of the segments analyzed in the report, is projected to record 12.6% CAGR and reach US$456.8 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Non-Enzymatic Dissociation Products segment is readjusted to a revised 11.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $107.1 Million, While China is Forecast to Grow at 11.1% CAGR

The Cell Dissociation market in the U.S. is estimated at US$107.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$148.7 Million by the year 2030 trailing a CAGR of 11.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.3% and 9.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Select Competitors (Total 44 Featured) -

  • American Type Culture Collection (ATCC)
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HiMedia Laboratories
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • PAN-Biotech GmbH
  • StemCell Technologies Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Cell Dissociation - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cell Dissociation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Cell Dissociation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Enzymatic Dissociation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Enzymatic Dissociation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Non-enzymatic Dissociation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Non-enzymatic Dissociation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Instruments & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Connective Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Connective Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Epithelial Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Epithelial Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Cell Dissociation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other Tissues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 19: World 8-Year Perspective for Other Tissues by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 21: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 23: USA 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 25: USA 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Canada 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030
  • JAPAN
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Japan 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Japan 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030
  • CHINA
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: China 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: China 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030
  • EUROPE
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Cell Dissociation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 47: Europe 8-Year Perspective for Cell Dissociation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Europe 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030
  • FRANCE
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: France 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: France 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030
  • GERMANY
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Germany 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Germany 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Italy 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Italy 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030
  • UNITED KINGDOM
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 73: UK 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 77: UK 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Cell Dissociation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Rest of World 8-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2023 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissues - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of World 8-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissues for the Years 2023 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Cell Dissociation by End-Use - Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of World 8-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Research & Academic Institutes and Other End-Uses for the Years 2023 & 2030

IV. COMPETITION